Back
Catheter Precision Vs. Plus Therapeutics Industry Stock Comparison
Buy
60
VTAK
Catheter Precision
Last Price:
0.51
Seasonality Move:
-1.88%
Sell
35
PSTV
Plus Therapeutics
Last Price:
1.26
Seasonality Move:
1.66%
Buy
60
Catheter Precision (VTAK)
is a Buy
Is Catheter Precision a Buy, Sell or Hold?
- The current Catheter Precision [VTAK] share price is $0.48. The Score for VTAK is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- VTAK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy, Sell or Hold?
- The current Plus Therapeutics [PSTV] share price is $1.31. The Score for PSTV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- PSTV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VTAK Stock Price Chart
What is Catheter Precision's stock price today?
-
The Catheter Precision share price today is $0.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VTAK is experiencing slight selling pressure.
PSTV Stock Price Chart
What is Plus Therapeutics's stock price today?
-
The Plus Therapeutics share price today is $1.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing slight selling pressure.
VTAK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 44.53 | Sell |
Chaikin Money Flow: | -687544 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.37 - 0.73) | Sell |
Bollinger Bands (100): | (0.07 - 3.03) | Sell |
PSTV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 46.56 | Sell |
Chaikin Money Flow: | -37669 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.29 - 1.41) | Sell |
Bollinger Bands (100): | (1.33 - 1.67) | Sell |
VTAK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.48 | Buy |
20-day SMA: | 0.59 | Sell |
50-day SMA: | 0.48 | Sell |
200-day SMA: | 3.32 | Sell |
8-day EMA: | 0.48 | Sell |
20-day EMA: | 0.52 | Sell |
50-day EMA: | 0.77 | Sell |
200-day EMA: | 5.27 | Sell |
PSTV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.31 | Sell |
20-day SMA: | 1.34 | Sell |
50-day SMA: | 1.4 | Sell |
200-day SMA: | 1.73 | Sell |
8-day EMA: | 1.3 | Buy |
20-day EMA: | 1.33 | Sell |
50-day EMA: | 1.4 | Sell |
200-day EMA: | 1.77 | Sell |
Catheter Precision Earnings Growth & VTAK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.70 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $4.90 per share.
Plus Therapeutics Earnings Growth & PSTV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.64 per share, and an increase next year of $0.17 per share.
Catheter Precision Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Plus Therapeutics Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |